Molecular Pharmaceutics
[ASAP] Dual Targeting of Integrin α<sub>v</sub>β<sub>3</sub> and Neuropilin‑1 Receptors Improves Micropositron Emission Tomography Imaging of Breast Cancer
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.1c01015
Molecular Pharmaceutics
[ASAP] Spray-Dried Monoclonal Antibody Suspension for High-Concentration and Low-Viscosity Subcutaneous Injection
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00039
Molecular Pharmaceutics
[ASAP] Discovery of a Cyclic Cell-Penetrating Peptide with Improved Endosomal Escape and Cytosolic Delivery Efficiency
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.1c00924
Molecular Pharmaceutics
[ASAP] Combined Probe Strategy to Increase the Enzymatic Digestion Rate and Accelerate the Renal Radioactivity Clearance of Peptide Radiotracers
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00051
Molecular Pharmaceutics
[ASAP] Liposome-Encapsulated Tiancimycin A Is Active against Melanoma and Metastatic Breast Tumors: The Effect of cRGD Modification of the Liposomal Carrier and Tiancimycin A Dose on Drug Activity and Toxicity
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.1c00753
Molecular Pharmaceutics
[ASAP] Improved Liver Delivery of Primaquine by Phospholipid-Free Small Unilamellar Vesicles with Reduced Hemolytic Toxicity
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.1c00520
Molecular Pharmaceutics
[ASAP] Zwitterionic Block Copolymer Prodrug Micelles for pH Responsive Drug Delivery and Hypoxia-Specific Chemotherapy
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.1c00518